The long term objective of this proposal is to understand the role of marine lipids on lesion formation in atherosclerosis. The proposal is based on four observations: (1) that smooth muscle cell (SMC) proliferation is an early and critical event in the formation of occlusive atherosclerotic lesions; (2) that ingestion of fish or fish oils containing n-3 polyunsaturated fatty acids (PUFAs) inhibits intimal thickening in experimental animals, and may decrease the incidence of coronary heart disease in man; (3) that cultured endothelial cells (EC) produce mitogens, especially a platelet-derived growth factor-like protein, that stimulate SMC proliferation in vitro; and (4) that growth factor production by cultured EC is regulatable and, as we have recently observed, is inhibited by fish oil emulsions and certain modified lipoproteins. To explain these observations, we propose that ingestion of fish oils results in an elevated level of specific marine lipids in plasma lipoproteins, that the altered lipoproteins inhibit EC production of growth factors, and that this regulatory mechanism is in part responsible for the observed decrease in SMC growth, and the proposed benefits of this diet. This hypothesis will be tested by pursuit of the following specific aims: 1. To characterize and identify the lipid(s) in marine oils that specifically inhibits EC production of growth factors. 2. To determine if cellular processing is required for the expression of the inhibitory activity of marine lipids. 3. To determine the biosynthetic step(s) regulated by marine lipids that causes the inhibition of growth factor production by EC. 4. To determine whether physiological lipoproteins enriched with marine lipids inhibit EC production of growth factors. 5. To determine if marine lipids inhibit the proliferation of cultured vascular SMC. Answers to these questions of vascular cell biology should contribute to our understanding of the cellular interactions of EC and SMC. The mechanistic insights resulting from this work may help to explain the recent epidemiological studies which suggest that diets rich in n-3 PUFAs are associated with reduced incidence of coronary heart disease, and may eventually lead to the development of pharmacologic inhibitors of atherogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL040352-04
Application #
3471920
Study Section
Pathology A Study Section (PTHA)
Project Start
1988-04-01
Project End
1993-03-31
Budget Start
1991-04-05
Budget End
1992-03-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Van Aalst, J A; Madura 2nd, J A; Deluca, D et al. (2000) Regional differences in phorbol 12-myristate 13-acetate stimulation of PDGF production in the normal canine aorta. J Vasc Surg 32:584-92
Madura 2nd, J A; Kaufman, B R; Margolin, D A et al. (1996) Regional differences in platelet-derived growth factor production by the canine aorta. J Vasc Res 33:53-61
Sa, G; Murugesan, G; Jaye, M et al. (1995) Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270:2360-6
Margolin, D A; Madura, J A; de la Motte, C A et al. (1995) Differential monocytic cell adherence to specific anatomic regions of the canine aorta. J Vasc Res 32:266-74
Ehrenwald, E; Chisolm, G M; Fox, P L (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 93:1493-501
Murugesan, G; Sa, G; Fox, P L (1994) High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ Res 74:1149-56
Ehrenwald, E; Fox, P L (1994) Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch Biochem Biophys 309:392-5
Fox, P L; Sa, G; Dobrowolski, S F et al. (1994) The regulation of endothelial cell motility by p21 ras. Oncogene 9:3519-26
Sa, G; Fox, P L (1994) Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem 269:3219-25
Margolin, D A; Kaufman, B R; DeLuca, D J et al. (1993) Increased platelet-derived growth factor production and intimal thickening during healing of Dacron grafts in a canine model. J Vasc Surg 17:858-66;discussion 866-7

Showing the most recent 10 out of 17 publications